Literature DB >> 1510008

Reproducibility of a symptomatic response to upright tilt in young patients with unexplained syncope.

F A Fish1, J F Strasburger, D W Benson.   

Abstract

Serial upright tilt testing has been advocated as a possible therapeutic end point in treating patients with recurrent syncope, but the reproducibility of such testing has not been well-established in the absence of therapy. In 21 patients with recurrent syncope and a symptomatic response to upright tilt testing, tilt was repeated following a 25- to 30-minute recovery. Syncope or presyncope was reproduced in 14 of 21 patients on repeat tilt; 4 of 21 patients experienced milder symptoms, and 3 of 21 patients remained entirely asymptomatic on repeat tilt. The pattern of physiologic response was different during initial and repeat tilt in 7 of the 21 patients. Blood pressure and heart rate (before and during symptoms) were similar for the group on initial and repeat tilt. The abnormal physiologic response and associated symptoms elicited during upright tilt testing for unexplained syncope can be reproduced on immediate repeat tilt testing in most patients. However, the frequently attenuated response during repeat testing may limit its use as a therapeutic end point in individual patients.

Entities:  

Mesh:

Year:  1992        PMID: 1510008     DOI: 10.1016/0002-9149(92)90199-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

1.  Intravenous cannulation of adolescents does not affect the modulation of autonomic tone assessed by heart rate and blood pressure variability.

Authors:  J M Stewart
Journal:  Clin Auton Res       Date:  2000-02       Impact factor: 4.435

2.  "Rate-drop response" cardiac pacing for vasovagal syncope. Rate-Drop Response Investigators Group.

Authors:  D G Benditt; R Sutton; M Gammage; T Markowitz; J Gorski; G Nygaard; J Fetter
Journal:  J Interv Card Electrophysiol       Date:  1999-03       Impact factor: 1.900

3.  Head-up tilt test: a highly sensitive, specific test for children with unexplained syncope.

Authors:  D Alehan; A Celiker; S Ozme
Journal:  Pediatr Cardiol       Date:  1996 Mar-Apr       Impact factor: 1.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.